Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

CD4+ DEPLETION RESULTS IN ROBUST CNS REBOUND AND LARGER MACROPHAGE RESERVOIRS

By Jimmy He PharmD, DScApril 4, 2022

…ART initiation. We observed significant CD4 depletion in the blood(95%), lymph nodes(70%) and spleen(50%) post CD4R1 administration, which was maintained throughout ATI. No difference was observed in time-to or set-point…

Diagnosing Extra Pulmonary Tuberculosis Using Xpert MTB/RIF: A Laboratory Algorithm

By Enthusiast Inc MDSeptember 29, 2014

…was investigated with the aim of establishing whether EPTB testing should be incorporated into the national testing algorithm. Methodology: EPTB specimens from 7916 hospitalized patients received over a 6-month period…

HCV 2k/1b Recombinant Form among Hepatitis C–Infected Genotype 2 Patients in Georgia

By Enthusiast Inc MDFebruary 27, 2015

…that 15 sequences of discordant sequences formed a clade with RF2k/1b reference sequences chosen from different countries. Remaining discordant sequence was found outside the RF2k/1b sub-branch and formed a cluster…

A T Cell-Targeting mRNA SIV Vaccine Extends Time to Rebound and Enhances Post-ART Viral Control

By Jimmy He PharmD, DScApril 26, 2024

…control. Methods: 16 RMs were infected with 5000IU of SIVmac239M and started on ART 9 days post-infection. Following viral suppression, RM were divided into 2 balanced groups that received 5…

391 – Ex Vivo Isolation and Characterization of Live, Envelope Expressing, SHIV-Infected CD4 T Cells

By Jimmy He PharmD, DScApril 18, 2025

…rhesus macaques were index sorted between Fiebig stages 1 and 6. For each animal lymph nodes (LNs) were longitudinally sampled 3 times, and blood was longitudinally sampled 5 times. SHIV…

LOSARTAN DOES NOT IMPROVE LYMPHATIC TISSUE FIBROSIS OR T-CELL RECOVERY IN HIV

By Jimmy He PharmD, DScApril 28, 2020

…of losartan (100mg) versus placebo among persons with HIV on ART with plasma HIV RNA <200 copies/mL. Participants underwent an inguinal lymph node (LN) biopsy at baseline and after 12…

HIV Pathogenesis: Current Understanding and Future Research

By Enthusiast Inc MDSeptember 29, 2014

Background: HIV is transmitted via mucosal and intravenous routes, replicating initially in CD4+ T cells at mucosal sites and draining lymph nodes. Following systemic dissemination, a major reservoir of infection…

NanoART Facilitated HIV-1 Clearance by a Mixed-Lineage Kinase 3 Inhibitor

By Enthusiast Inc MDSeptember 29, 2014

…the antiretroviral activities of our nanoformulated long-acting ART Methodology: Isobaric tag for relative and absolute quantitation (iTRAQ) was performed in URMC-099 treated monocyte-derived macrophages (MDM) seeking potential antiretroviral actions. Nanoformulated…

RAPIDLY GROWING HIV TRANSMISSION CLUSTERS IN THE UNITED STATES, 2013–2016

By Enthusiast Inc MDMarch 5, 2018

…py (median: 44 per 100 py). Compared with the 50,847 persons not in rapidly growing clusters, the 903 persons in rapidly growing clusters were disproportionately young men who have sex…

ISOLATION OF TRANSLOCATING BACTERIA IN PROGRESSIVE SIV INFECTION OF RHESUS MACAQUES

By Enthusiast Inc MDMarch 5, 2019

…macaques and identified them subsequent to live culture. Liver, mesenteric lymph node, and spleen samples were taken during necropsy from one uninfected and twenty chronically SIV– or SHIV−infected RM, including…

←1
23456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869
…7071727374…
7576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top